IGFBP3 and metabolic dysfunction-associated steatotic liver disease: In addition, the IGFBP3 rs2854744 “T” allele was significantly overrepresented in NAFLD patients than the controls (P = 0.008; OR = 1.85; 95%CI = 1.23-2.94).